$APVO 4/A SEC Filings

Filed On	Filing
07 Mar 2023	Form 4/A: Abdun-Nabi Daniel, Director Holds 41,762 shares of Common Stock
21 Mar 2018	Form 4/A: White Marvin L, Director Bought 100,000 shares ($293K)
27 Sep 2016	Form 4/A: White Marvin L, Director Granted 200,475 Stock Option (right to buy)
27 Sep 2016	Form 4/A: Stromatt Scott C, Chief Medical Officer and SVP Granted 132,885 Restricted Stock Unit
27 Sep 2016	Form 4/A: Lamothe Jeffrey G., SVP, CFO and Treasurer Granted 50,680 Restricted Stock Unit
04 Aug 2016	Form 4/A: Emergent BioSolutions Inc., 10% owner Acquired 20,228,849 shares (Other Transaction) · Disposed of 20,229,849 shares (Other Transaction)

Comments